Truffle Capital is a venture capital and private equity firm investing in technology companies that is headquartered in Paris, France and was founded in 2001 by Bernard-Louis Roques, Henri Moulard, Jean-Francois Fourt, and Philippe Pouletty. According to the firms website 9 (as of December 2019), Truffle Capital has €500 under management, has made 75 investments since its founding, and has 24 employees.
The firm focuses on investing in information technology, financial technology, insurance technology, biotechnology, and medical technology companies.
Timeline
Funded Companies
A synthetic biology company making antibiotics and bioactives.
Altimmune is a therapeutics, treatment, and vaccine development company that looks to find response and prevention solutions
Actility is a software company providing low power wide area (LoRaWAN and 3GPP connectivity) network connectivity management.
Pharnext is a very well advanced clinical-stage biopharmaceutical company
CARBIOS is a Saint-Beauzire, Haute-Loire-based company.
Theradiag is a France-based medical diagnostics company developing tracker kits and biotherapy monitoring kits.
People
Further reading
Documentaries, videos and podcasts
Companies
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Nathan Lippi
This is a filler - 3
Vadym Dzina
Software developer, manager and IT consultant. From Kyiv, Ukraine. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Henry Ogolla
Passionate about reading and writing. - 6
Lea Isabella Boreland
Customer Success at Golden - 7
Jed Christiansen
Special Projects & Business Development at Golden, Founder - Seed-DB.
